KPTI icon

Karyopharm Therapeutics
KPTI

Overview Fund Trends Analyst Outlook Journalist POV

54 hedge funds and large institutions have $204M invested in Karyopharm Therapeutics in 2013 Q4 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$53.8M
2
+$19.8M
3
+$18M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.6M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$10.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$53.8M
2
$32.6M
3
$19.8M
4
$18M
5
$11.6M
6
$10.4M
7
$7.49M
8
$5.53M
9
$4.89M
10
$2.83M
11
$2.74M
12
$2.54M
13
$2.51M
14
$2.49M
15
$2.43M
16
$2.29M
17
$2.07M
18
$1.91M
19
$1.79M
20
$1.72M
21
$1.41M
22
$1.07M
23
$890K
24
$822K
25
$812K
1
2 3